Trial Profile
The effect of paclitaxel combined with thalidomide on refractory metastatic osteosarcoma:a phase II clinical trial.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Apr 2016
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Thalidomide (Primary)
- Indications Osteosarcoma
- Focus Adverse reactions; Therapeutic Use
- 31 Jan 2013 New trial record